thalidomide has been researched along with orabase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dyckhoff, G; Herold-Mende, C; Vasvari, G | 1 |
| Cao, LH; Han, F; Li, AH; Liu, JB; Liu, M; Luo, RZ; Zheng, W; Zhou, JH | 1 |
2 other study(ies) available for thalidomide and orabase
| Article | Year |
|---|---|
Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology--a rebuttal.
Topics: Angiogenesis Inhibitors; Apoptosis; Carboxymethylcellulose Sodium; Cell Line, Tumor; Cell Size; Cell Survival; Dimethyl Sulfoxide; Doxorubicin; Endothelial Cells; Endothelium, Vascular; Humans; Solvents; Thalidomide | 2005 |
Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Liver Neoplasms, Experimental; Mice; Neovascularization, Pathologic; Random Allocation; Statistics, Nonparametric; Sulfur Hexafluoride; Thalidomide; Ultrasonography | 2011 |